This is a prospective, randomized, open-label, two-arm phase 2 trial that will evaluate whether the use of Pulsed Low-Dose-Rate radiation technique, as compared to standard radiation, is associated with reduced rates of clinically significant esophagitis during and following chemoradiation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
New prescription for narcotics
Timeframe: Up to 6 weeks after radiation treatment
Increasing existing narcotics
Timeframe: Up to 6 weeks after radiation treatment
Oral intake
Timeframe: Up to 6 weeks after radiation therapy
Medical College of Wisconsin Cancer Center Clinical Trials Office